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Xing Fu,1 Meijun Zhu,2 Shuming Zhang,2 Marc Foretz,3,4,5 Benoit Viollet,3,4,5 and
Min Du1

Obesity Impairs Skeletal Muscle
Regeneration Through Inhibition
of AMPK

Obesity is increasing rapidly worldwide and is accompanied by many complications, including impaired muscle regeneration. The obese condition is known to inhibit
AMPK activity in multiple tissues. We hypothesized that
the loss of AMPK activity is a major reason for hampered muscle regeneration in obese subjects. We found
that obesity inhibits AMPK activity in regenerating
muscle, which was associated with impeded satellite
cell activation and impaired muscle regeneration. To
test the mediatory role of AMPKa1, we knocked out
AMPKa1 and found that both proliferation and differentiation of satellite cells are reduced after injury and that
muscle regeneration is severely impeded, reminiscent
of hampered muscle regeneration seen in obese subjects. Transplanted satellite cells with AMPKa1 deﬁciency had severely impaired myogenic capacity in
regenerating muscle ﬁbers. We also found that attenuated muscle regeneration in obese mice is rescued by
AICAR, a drug that speciﬁcally activates AMPK, but
AICAR treatment failed to improve muscle regeneration
in obese mice with satellite cell–speciﬁc AMPKa1
knockout, demonstrating the importance of AMPKa1
in satellite cell activation and muscle regeneration. In
summary, AMPKa1 is a key mediator linking obesity
and impaired muscle regeneration, providing a convenient drug target to facilitate muscle regeneration in
obese populations.

Skeletal muscle, which accounts for 40% of body mass, is
responsible for locomotion and is the major site for
glucose and fatty acid utilization, playing a key role in
preventing obesity and type 2 diabetes (1–3). Skeletal
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muscle regeneration is an integrated part of the physiological process in skeletal muscle. In both exercise-induced
muscle damage and muscle trauma, skeletal muscle regeneration is required for recovery after injury (4,5). Moreover, sustained but attenuated muscle regeneration is
indispensable in the etiology of muscular diseases, such
as Duchenne muscular dystrophy (6).
Satellite cells are the major postnatal myogenic cells in
skeletal muscle (7). In response to muscle damage, satellite cells are activated and undergo asymmetric division,
with one daughter cell to replenish the original cell and
the other cell to undergo myogenic differentiation (8).
The myogenic cells then fuse with damaged muscle ﬁbers
to repair or form new muscle ﬁbers to replace the necrotic
ones. Improper muscle regeneration leads to muscle atrophy and impairment of muscle contractile function (9–
11). On the other hand, successful muscle regeneration
requires both sufﬁcient quantity and proper myogenic
differentiation of satellite cells (12). Proliferation of satellite cells is regulated by growth factors (13), whereas
myogenic differentiation is regulated by myogenic regulatory factors (MRFs), including Myf5, MyoD, myogenin,
and MRF4 (3); disrupted expression of MRFs negatively
affects muscle regeneration (14).
AMPK is known for its regulatory role in energy
metabolism (15). Metabolic disorders such as obesity
and type 2 diabetes have become major health problems
worldwide and are associated with attenuated muscle regeneration (16,17) and reduced AMPK activity (18). However, the role of AMPK in impaired muscle regeneration
due to obesity and type 2 diabetes has not been deﬁned.
AMPK is a heterotrimeric enzyme with an a-catalytic
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RESEARCH DESIGN AND METHODS
Induction of AMPKa1 Knockout in R26Cre/AMPKa1ﬂ/ﬂ
Mice and Pax7Cre/AMPKa1ﬂ/ﬂ Mice

Three- to 4-month-old R26 Cre /AMPKa1 ﬂ/ﬂ mice and
Pax7Cre/AMPKa1ﬂ/ﬂ mice were injected intraperitoneally
with tamoxifen 100 mg per 1 kg body weight per day
for 5 continuous days to induce AMPKa1 knockout
(KO) (22). AMPKa1ﬂ/ﬂ mice treated with tamoxifen
were used as controls. Mice were allowed to rest for at
least 3 days after the last tamoxifen injection before further experiments.
Induction of Muscle Regeneration

To induce muscle regeneration, 100 mL of 10 mmol/L
cardiotoxin (CTX) was injected into each tibialis anterior
(TA) muscle of 3–4-month-old mice (10,21).
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gel electrophoresis was performed to conﬁrm that only a single product of the correct size was ampliﬁed. Relative mRNA
content was normalized to 18S rRNA content (21).
Immunoblotting Analysis

Immunoblotting analysis was performed as previously
described using an Odyssey Infrared Imaging System
(Model 9120, LI-COR Biosciences, Lincoln, NE) (23).
Band density was normalized to b-tubulin content.
Immunocytochemical Staining

Cells grown on multiple-well plates were ﬁxed in cold
methanol for 10 min, permeabilized with 0.1% Triton
X-100 for 5 min, blocked with 1% BSA, and incubated with
primary antibodies at 4°C overnight. Cells were then stained
with corresponding secondary antibodies (1:1,000) for 1 h.
Images were taken using an EVOS microscope.
Immunohistochemical Staining

TA muscle ﬁxed in 4% paraformaldehyde or fresh TA
muscle was frozen in isopentane cooled in liquid nitrogen.
Frozen tissue was sectioned (10 mm thick). Sections of
ﬁxed tissue were heated in citrate buffer for 20 min,
blocked with 5% goat serum in TBS containing 0.3% Triton X-100 for 2 h, and stained with primary antibodies
overnight and corresponding ﬂuorescent secondary
antibodies for 1 h. Sections of unﬁxed tissue were
stained without antigen retrieval. Sections were then
mounted in a mounting medium (Vector Laboratories,
Burlingame, CA).

FACS

Quantiﬁcation of Pax7+ Satellite Cells and Embryonic
Myosin Heavy Chain–Positive Muscle Fibers

TA muscle was digested in DMEM with collagenase D and
dispase II as previously described (21). Cells were blocked
in anti-mouse CD16/CD32 antibody and then stained with
anti-mouse CD45 PE-Cy7, anti-mouse TER119 PE-Cy7,
anti-mouse CD31 PE-Cy7, anti-mouse Sca-1 APC-Cy7, and
anti-mouse integrin a7 APC antibodies or anti-mouse F4/80
Alexa Fluor 488 and anti-mouse Ly6G/C APC antibodies.
Stained cells were sorted on FACSaria (BD Biosciences,
San Jose, CA) and analyzed by FlowJo (Tree Star, Inc.,
San Carlos, CA). Gates were made based on Fluorescence
Minus One control (Supplementary Fig. 2).

Statistics

Oil Red O Staining

Oil red O staining was performed as previously described
(10). Brieﬂy, cells were ﬁxed in 10% formalin for 30 min,
stained with oil red O in 60% isopropanol for 10 min, and
counterstained with hematoxylin. Adipogenic efﬁciency
was calculated by dividing the number of oil red O–positive
cells by the number of total cells.
Real-Time Quantitative PCR

cDNA was synthesized using a reverse transcription kit (BioRad, Hercules, CA). Primers are listed in Supplementary
Table 1. Real-time PCR (RT-PCR) was carried out using
a CFX RT-PCR detection system (Bio-Rad) with a SYBR Green
RT-PCR kit (Bio-Rad). After ampliﬁcation, a melting curve
(0.01°C/s) was used to conﬁrm product purity, and agarose

Pax7+ cells with nuclei identiﬁed by DAPI staining were
classiﬁed as satellite cells. For each TA muscle sample, the
total number of satellite cells and embryonic myosin
heavy chain–positive (EMH+) muscle ﬁbers on four randomly selected microscopic ﬁelds of each of three sections
at various depths of muscle were counted (four ﬁelds per
section, three sections per muscle). Average numbers
obtained from the three examined sections of each muscle
sample were used as a biological replicate for comparative
analysis.
All data are expressed as mean 6 SEM. Data were analyzed
using the general linear model in SAS statistical software
(Version 9.2, SAS Institute Inc., Cary, NC), and the t or
Tukey range test was used to determine signiﬁcance of differences among means. P , 0.05 was considered signiﬁcant.
RESULTS
Diet-Induced Obesity Is Associated With Reduced
AMPK Activity in Satellite Cells During Muscle
Regeneration

We previously reported that AMPKa1 is the dominant
a-subunit in myogenic cells and that lack of AMPKa1
attenuates myogenic differentiation (Supplementary Fig.
1A) (20,21). AMPK activity has also been reported to be
inhibited in multiple tissues of obese rodents and humans
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subunit and two isoforms, a1 and a2 (19). We previously
identiﬁed the stimulatory effect of AMPKa1, the dominant AMPKa isoform in satellite cells, on myogenin expression and fusion into myotubes (20,21), which led us
to hypothesize that AMPKa1 facilitates muscle regeneration and that obesity impedes muscle regeneration mainly
through inhibition of AMPK. In the present study, we
found that the lack of AMPKa1 activity reduces the density of satellite cells and their differentiation after muscle
injury and that activation of AMPK rescues muscle regeneration in obese mice. Thus, AMPK is a therapeutic target
for facilitating muscle regeneration in patients with obesity and diabetes, whereas AMPK is inhibited.

Fu and Associates
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which reduced p-AMPKa levels in satellite cells; in contrast, 125 mmol/L AICAR neutralized the negative effect
of TNFa on AMPKa phosphorylation (Fig. 1H).
Diet-Induced Obesity Attenuates Muscle Regeneration

Muscle regeneration in control and obese mice was then
compared. At 3 days postinjury, most muscle ﬁbers were
necrotic in muscle from both control and obese mice,
which were enlarged and lightly stained by hematoxylineosin (H-E) (Fig. 2B). However, regenerating muscle of
control mice contained many more newly formed ﬁbers,
which was conﬁrmed by IHC staining against EMH,
a marker of regenerated ﬁbers (3) (Fig. 2A and B). The
difference was also observed at 7 days postinjury. Although well-restored muscle structure with new ﬁbers
was observed in control mice, a much smaller number
of regenerated ﬁbers and poorly restored structure were
seen in obese mice (Fig. 2C and E). Consistently, at 3 days
postinjury, the expression of genes important for myogenesis, including Pax7 and MRFs (Myf5, MyoD, and
myogenin), was lower in regenerating muscle from obese
than from control mice (Fig. 2E). However, myogenic differentiation was not different between isolated satellite
cells of control and obese mice possibly because of the lack
of difference in AMPK activity in vitro (Supplementary
Fig. 2I). Satellite cells are indispensable for muscle regeneration (29). The density of Pax7+ satellite cells was lower
in muscle from obese than from control mice at both 3
and 7 days postinjury, indicating a reduced satellite cell
population (Fig. 2F and G). In agreement, FACS showed
that CD452/TER1192/CD312 (Lin2)Sca-12/integrin a7+
satellite cells were less in muscle of obese mice than in
control mice, indicating that the reduced satellite cell pool
might contribute to attenuated muscle regeneration (Fig.
2H and Supplementary Fig. 3C) (30).
To further trace muscle regeneration, we used Pax7Cre/
tdomato,EGFP mice in which satellite cells and their derived myogenic cells and regenerated muscle ﬁbers carry
green ﬂuorescence after tamoxifen treatment. Obesity reduced the number of green ﬂuorescent ﬁbers in regenerating muscle at 3 and 7 days postinjury compared with
the control condition (Supplementary Fig. 4A and B).
Muscle Regeneration in AMPKa1 KO Mice Was
Attenuated

Because of the dominant expression of AMPKa1 in satellite cells and the reduced AMPK activity in activated
satellite cells from obese mice, we hypothesized that
attenuated muscle regeneration in obese mice is due to
reduced AMPKa1 activity in satellite cells (Supplementary
Figs. 1A and 2D). A mouse strain with constitutional
AMPKa1 KO was used to mimic the inhibition in AMPK
activity during muscle regeneration due to obesity. At 3
days postinjury, fewer newly formed muscle ﬁbers were
found in AMPKa1 KO than in wild-type (WT) mice as
shown by H-E and IHC staining (Supplementary Fig. 5A
and B). At 7 days postinjury, better restoration of muscle
structure with fewer necrotic muscle ﬁbers and more
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(24,25). To test whether AMPK activity was downregulated in muscle of obese mice, which attenuated muscle
regeneration, C57BL/6 mice were fed a 60% high-fat diet
for 3 months to induce obesity (Fig. 1A–C). Damage to TA
muscle was induced by CTX injection. The p-AMPKa/
AMPKa and p-ACC/ACC ratios were lower in regenerating
muscle from obese mice than that from control mice at
3 days postinjury, indicating a lower AMPK activity in
muscle of obese mice after injury (Supplementary Fig.
2A). However, no difference was found in uninjured muscle between control and obese mice (Supplementary Fig.
2B). Due to different cell composition in uninjured and
injured muscle, satellite cells were isolated from injured
muscle of control and obese mice to better understand the
change of AMPK activity in these cells. No difference was
detected, which could be the result of the isolation process and the following in vitro culture that diminished the
difference (Supplementary Fig. 2C). Immunohistochemical (IHC) staining, therefore, was performed to examine
the p-AMPKa level in satellite cells in vivo. AMPKa1 expression was detected in satellite cells in both uninjured
and injured muscle (Fig. 1D). However, p-AMPKa was
only detected in satellite cells in injured muscle, suggesting an activation of AMPK in satellite cells after injury
(Fig. 1D). Of note, more satellite cells stained positive for
p-AMPKa in injured muscle from control mice than from
obese mice, indicating that AMPK activation in satellite
cells after injury is negatively affected in obese mice (Fig.
1D and E).
No difference in the expression of AMPKa1 and -a2
subunits was found between satellite cells isolated from
control and obese mice during muscle regeneration (Supplementary Fig. 2D and E) or in the expression of the two
AMPK kinases LKB1 and CAMKK2 (Supplementary Fig.
2F). In addition, the ATP/AMP ratio was not different
between injured muscle from control and that from obese
mice, showing that AMPK activation pathways were not
affected in satellite cells as a result of obesity (Supplementary Fig. 2G). Moreover, no difference in muscle ﬁber
composition was found between control and obese mice,
which rules out the possible inﬂuence of altered muscle
ﬁber composition in muscle regeneration (Supplementary
Fig. 2H).
Tumor necrosis factor-a (TNFa) downregulates AMPK
activity in muscle (18), and muscle regeneration involves
inﬁltration of macrophages that secrete cytokines, including TNFa (26,27). An increase of macrophage inﬁltration
was observed in obese mice as measured by FACS, but no
difference was found in the ratio of M1 to M2 macrophages, suggesting no defect in macrophage polarization
(Fig. 1F and Supplementary Fig. 3A and B) (28). Consistently, the expression of TNFa, an M1 macrophage
marker, and transforming growth factor-b (TGFb), an
M2 macrophage marker, were both higher in injured muscle from obese compared with control mice (Fig. 1G). To
test whether TNFa affects AMPK activity in satellite cells,
isolated satellite cells were treated with TNFa 10 ng/mL,
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Figure 1—Reduced AMPK activity in satellite cells of obese mice during muscle regeneration. A: Body weight of male mice fed a control
diet (CD) and a high-fat diet (HFD). B: Glucose tolerance test of CD and HFD mice. C: Insulin tolerance test of CD and HFD mice. D: IHC
staining identifying AMPKa1 expression and p-AMPKa level in satellite cells of muscle before injury and 3 days postinjury (dpi). The dottedline inset on each image shows magniﬁcation of the area marked by the solid-line box. Scale bars = 100 mm. E: Quantiﬁcation of satellite
cells staining positive for p-AMPKa in muscle of CD and HFD mice 3 dpi. F: FACS identifying M1 (Q2) and M2 (Q3) macrophages in
regenerating muscle of CD and HFD mice. G: RT-PCR of TGFb and TNFa expression in muscle of CD and HFD mice at 3 dpi. H: Western
blot analysis of p-AMPKa and AMPKa levels in WT satellite cells treated with 10 ng/mL TNFa with and without 125 mmol/L AICAR for 12 h
and untreated control. Data are mean 6 SEM (n = 3). *P < 0.05, **P < 0.01, ***P < 0.0001 vs. control.
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regular-shaped muscle ﬁbers was observed in WT than in
AMPKa1 KO mice (Fig. 3A and B). Consistently, at 14
days postinjury, while many necrotic muscle ﬁbers and
immature muscle ﬁbers remained in the muscle of
AMPKa1 KO mice, muscle structure was restored in WT
mice with only a few EMH+ muscle ﬁbers close to normal
size remaining, indicating better regeneration than in
AMPKa1 KO mice (Fig. 3A and B).

Satellite Cell Density in Undamaged Muscle and
Regenerating Muscle of AMPKa1 KO Mice Was Lower
Than in WT Mice

We then tested whether AMPKa1 ablation alters satellite
cell population in muscle during muscle regeneration. As
expected, IHC staining showed that the density of Pax7+
satellite cells was lower in AMPKa1 KO than in WT mice
at 3, 7, and 14 days postinjury (Fig. 3C and Supplementary
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Figure 2—Attenuated muscle regeneration in mice with diet-induced obesity. TA muscle of mice fed a control diet (CD) and a high-fat diet
(HFD) were injured by CTX injection. A: Regeneration of TA muscle at 3 days postinjury (dpi) examined by H-E staining showing necrotic
muscle ﬁbers (#) and regenerating muscle ﬁbers (*). B: IHC staining of EMH+ muscle ﬁbers in TA muscle at 3 dpi and quantiﬁcation. C:
Regeneration of TA muscle at 7 dpi examined by H-E staining showing necrotic muscle ﬁbers (#) and regenerating muscle ﬁbers (*). D: IHC
staining of EMH+ muscle ﬁbers in TA muscle at 7 dpi and quantiﬁcation. E: Pax7, Myf5, MyoD, and myogenin mRNA levels in TA muscle at
3 dpi. F and G: IHC staining of Pax7+ satellite cells in TA muscle at 3 dpi (F) and 7 dpi (G) and quantiﬁcation. The dotted-line inset on each
image shows magniﬁcation of the area marked by the solid-line box. H: FACS for Lin2/Sca-12/integrin a7+ satellite cells in TA muscle at
7 dpi. Data are mean 6 SEM (n = 3). Scale bars = 200 mm. *P < 0.05, **P < 0.01, ***P < 0.0001 vs. control.
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Figure 3—Impaired muscle regeneration efﬁciency in AMPKa1 KO mice. TA muscle of WT and AMPKa1 KO mice was injured by CTX
injection. A: Regeneration of TA muscle at 7 and 14 days postinjury (dpi) examined by H-E staining showing necrotic muscle ﬁbers (#) and
regenerating muscle ﬁbers (*). B: EMH+ muscle ﬁbers in TA muscle at 7 and 14 dpi detected by IHC staining and quantiﬁcation of EMH+
muscle ﬁbers. C and D: IHC staining for Pax7+ satellite cells (arrowheads) in TA muscle at 7 dpi (C) and before injury (D). The dotted-line
inset on each image shows magniﬁcation of the area marked by the solid-line box. E: FACS for Lin2/Sca-12/integrin a7+ satellite cells in TA
muscle before injury and at 7 dpi. F and G: Pax7, Myf5, MyoD, and myogenin mRNA levels before injury (F), and 7 dpi (G). H: Myogenic
differentiation of Lin2/Sca-12/integrin a7+ cells isolated from undamaged muscle measured by immunocytochemical staining for myosin
heavy chain (MHC). I: Myf5, MyoD, and myogenin mRNA levels in WT satellite cells and AMPKa1 KO satellite cells 1 day after induction of
myogenic differentiation. Data are mean 6 SEM (n = 3). Scale bars = 200 mm. *P < 0.05, **P < 0.01 vs. control.
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Fig. 5C and D). In agreement, Lin2/Sca-12/integrin a7+
satellite cells were reduced in AMPKa1 KO muscle (Fig.
3E). Consistently, the density of satellite cells was also
lower in undamaged muscle of AMPKa1 KO than in WT
mice (Fig. 3D and E). These data suggest that the reduced
satellite cell population in AMPKa1 KO mice during muscle
regeneration was partially the result of the reduced satellite
population in AMPKa1 KO mice before muscle injury.
Expression of Myogenic Genes Was Reduced
in AMPKa1 KO Regenerating Muscle

Because of the reduced satellite cell population and
hampered muscle structure restoration, we wondered

whether the transcription of Pax7 and MRFs was also
affected due to AMPKa1 KO. In undamaged muscle, transcription levels of Pax7, Myf5, and myogenin were lower in
AMPKa1 KO than in WT muscle (Fig. 3F), which could be
attributed to reduced satellite cell number due to AMPKa1
KO (20,21). At 3 and 7 days postinjury, all tested MRFs
were transcribed at lower levels in AMPKa1 KO than in
WT muscle, except the MyoD level at 3 days postinjury (P =
0.077) (Fig. 3G and Supplementary Fig. 5E). Lin2/Sca-12/
integrin a7+ satellite cells were isolated from TA muscle of
WT and AMPKa1 KO mice, and their myogenic differentiation was found to be impaired due to AMPKa1 KO (Fig.
3H and I). In aggregate, these data show that impaired
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Figure 4—Enhanced ﬁbrogenesis by AMPKa1 KO in muscle during regeneration. A and B: Adipogenic differentiation of Lin2/Sca-1+
cells isolated from undamaged WT and AMPKa1 KO muscle (A) and from WT and AMPKa1 KO muscle at 7 days postinjury (dpi) (B) as
measured by oil red O staining. C: Quantiﬁed adipogenic efﬁciencies of Lin2/Sca-1+ cells shown in A and B expressed as percentage of
oil red O–positive cells. D: TCF4 and IGF-I mRNA levels in WT and AMPKa1 KO nonmyogenic cells isolated from muscle at 7 dpi. E:
TCF4 and IGF-I mRNA levels in WT and AMPKa1 KO muscle at 7 dpi. F: IHC staining of Tcf4+ ﬁbroblasts in WT and AMPKa1 KO
regenerating muscle at 7 dpi. The dotted-line inset on each image shows magniﬁcation of the area marked by the solid-line box. G:
Trichrome staining of WT and AMPKa1 KO TA sections at 14 dpi. Data are mean 6 SEM (n = 3). Scale bars = 200 mm. *P < 0.05, **P <
0.01, ***P < 0.0001 vs. control.
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muscle regeneration in AMPKa1 mice might result from
a combined effect of reduced satellite cell number and their
myogenic differentiation.
AMPKa1 KO Promoted Fibrosis in Regenerating
Muscle

Excessive ﬁbrogenesis is associated with impaired muscle
regeneration (31). To explore whether AMPKa1 KO
affects ﬁbrogenesis, we isolated Lin2/Sca-1+ ﬁbro/adipogenic progenitor cells (10,32). Oil red O staining showed
that adipogenesis was reduced in AMPKa1 KO compared
with WT Lin2/Sca-1+ cells (Fig. 4A–C). In addition, newly
formed adipocytes in AMPKa1 KO Lin2/Sca-1+ cells were
clustered, suggesting a smaller percentage of cells undergoing adipogenic differentiation. Because ﬁbro/adipogenic
progenitor cells are dipotential with both adipogenic and
ﬁbrogenic capacity, the reduction in adipogenesis suggests

a corresponding increase in ﬁbrogenic commitment due to
AMPKa1 KO. Indeed, the expression of TCF4, a marker of
ﬁbroblasts, was higher in AMPKa1 KO than in WT Lin2/
Sca-1+ cells isolated from regenerating muscle (Fig. 4D),
showing a larger population of ﬁbroblasts in regenerating
AMPKa1 KO muscle (33). These data are consistent with
previous reports showing the inhibitory effect of AMPK
on ﬁbrogenesis in several examined tissues (34,35). In
addition, a higher level of Tcf4 expression and more
Tcf4+ ﬁbroblasts were detected in AMPKa1 KO than in
WT TA muscle at 7 days postinjury (Fig. 4E and F).
Trichrome staining at 14 days postinjury showed more
collagen deposition in AMPKa1 KO TA muscle, clearly
showing enhanced ﬁbrogenesis in regenerating AMPKa1
KO muscle (Fig. 4G).
Despite the negative effect of excessive ﬁbrosis on muscle
regeneration, other studies showed that intramuscular
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Figure 5—Impaired muscle regeneration efﬁciency in conditional AMPKa1 KO mice. TA muscle of tamoxifen-treated AMPKa1ﬂ/ﬂ mice and
conditional AMPKa1 KO (R26Cre/AMPKa12/2) mice were injured by CTX injection. A: Regeneration of TA muscle at 7 and 14 days postinjury
(dpi) examined by H-E staining showing necrotic muscle ﬁbers (#) and regenerating muscle ﬁbers (*). B: EMH+ muscle ﬁbers in TA muscle at
7 and 14 dpi detected by IHC staining and quantiﬁcation of EMH+ muscle ﬁbers. C: IHC staining for Pax7+ satellite cells in TA muscle at 7 and
14 dpi. The dotted-line inset on each image shows magniﬁcation of the area marked by the solid-line box. D: FACS for Lin2/Sca-12/integrin
a7+ satellite cells in TA muscle 7 days after CTX injection. Data are mean 6 SEM (n = 3). Scale bars = 200 mm. *P < 0.05, **P < 0.01 vs.
control.
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ﬁbrogenic cells promote satellite cell proliferation
(10,33,36). We then tested the expression level of
IGF-I, a ﬁbroblast-expressed growth factor stimulating
satellite cell proliferation, in isolated nonmyogenic cells
from muscle (37,38). IGF-I was expressed at a higher level
in AMPKa1 KO than in WT nonmyogenic cells (Fig.
4D). Consistently, IGF-I expression was higher in
AMPKa1 KO than in WT regenerating TA muscle
(Fig. 4E). These results suggest that AMPKa1 KO
enhances ﬁbrosis, which might partially negate the
reduced satellite cell number due to AMPKa1 KO in
vivo.

To eliminate the impact of AMPKa1 KO on muscle before
injury and better understand the function of AMPKa1
during muscle regeneration, we used a conditional AMPKa1
KO, R26Cre/AMPKa1ﬂ/ﬂ mice with ﬂoxed AMPKa1 genes,
which are deleted in response to tamoxifen treatment
(Supplementary Fig. 1A and B). Three-month-old R26Cre/
AMPKa1ﬂ/ﬂ mice were induced for AMPKa1 deletion followed by CTX-induced muscle injury in TA muscle. Muscle
injury was induced immediately after induction of
AMPKa1 KO to avoid differences in satellite cell density
between tamoxifen-treated control (AMPKa1ﬂ/ﬂ) mice
and conditional AMPKa1 KO (R26Cre/AMPKa12/2) mice
at the time of injury. Nevertheless, fewer regenerated
EMH + muscle ﬁbers were observed in conditional
AMPKa1 KO mice than in control mice at 7 days postinjury (Fig. 5A and B). Fourteen days after injury, the
structure of TA muscle of control mice restored much
better than that in conditional AMPKa1 KO mice (Fig.
5A). EMH staining showed that many thin EMH+ muscle
ﬁbers remained in the muscle from conditional AMPKa1
KO muscle at 14 days postinjury, whereas only a few
regular-shaped EMH+ muscle ﬁbers were seen in control
mice (Fig. 5B). These data show that muscle regeneration
in conditional AMPKa1 KO mice was less efﬁcient than

in control mice, independent of the initial satellite cell
density.
Decreased satellite cell number was observed in muscle
from conditional AMPKa1 KO mice compared with control mice at 7 and 14 days postinjury (Fig. 5C), which was
conﬁrmed by FACS data (Fig. 5D). In combination, these
data show that lack of AMPKa1 affects muscle regeneration through reducing satellite cell proliferation and
differentiation.
AMPKa1 KO Reduced Myogenic Capacity of
Transplanted Satellite Cells In Vivo

To further examine the effect of AMPKa1 KO on myogenic
capacity of satellite cells during muscle regeneration in vivo,
we cotransplanted AMPKa1+/+/EGFP satellite cells and
R26Cre/AMPKa1ﬂ/ﬂ/DsRed satellite cells into regenerating
TA muscle of WT mice. The mice were treated with tamoxifen each day starting on the same day of satellite transplantation until 2 days postinjury to induce AMPKa1 KO in
transplanted R26Cre/AMPKa1ﬂ/ﬂ/DsRed satellite cells while
avoiding the potential impact of AMPKa1 KO on establishing transplanted cells. Indeed, 2 days after satellite cell
transplantation, no difference in the number of red and
green ﬂuorescent cells was observed (Fig. 6A), which indicated that the retention of transplanted R26Cre/AMPKa1ﬂ/ﬂ/
DsRed and AMPKa1+/+/EGFP satellite cells was not different. However, 14 days after satellite cell transplantation,
a larger number of green muscle ﬁbers than red muscle
ﬁbers was observed, showing the reduced myogenic capacity of transplanted satellite cells after AMPKa1 KO
(Fig. 6A and B). In contrast, in the TA muscle of
control mice, which were not treated with tamoxifen,
the same number of green and red muscle ﬁbers was observed at 14 days after transplantation, indicating an equal
myogenic capacity of green and red satellite cells when
AMPKa1 expression is intact (Supplementary Fig. 6).
These data unequivocally demonstrate that AMPKa1
is important for the myogenesis of satellite cells during
muscle regeneration.

Figure 6—Reduced myogenesis in transplanted satellite cells with AMPKa1 KO during muscle regeneration. A: One day after CTX injection at TA
muscle, 3 3 104 AMPKa1+/+/EGFP satellite cells and 3 3 104 R26Cre/AMPKa1ﬂ/ﬂ/DsRed satellite cells were transplanted into each TA muscle of
WT recipient mice. The recipient mice were treated with tamoxifen for 3 days from the day of transplantation. TA muscle was isolated at 2 days (top
row) and 14 days (bottom row) after satellite cell transplantation and immunostained to identify muscle ﬁbers derived from transplanted satellite
cells. The dotted-line insets on each image show magniﬁcation of the corresponding areas marked by the solid-line boxes. Scale bars = 200 mm.
B: Numbers of muscle ﬁbers formed by transplanted myoblasts at 14 days after satellite cell transplantation in three independent experiments.
Data are mean 6 SEM (n = 3). dpt, days posttransplantation.
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Figure 7—Attenuated AMPK activity and muscle regeneration in diet-induced obesity is rescued by AICAR treatment. TA muscle of mice
fed a control diet (CD), obese mice fed a high-fat diet (HFD), and obese mice treated with AICAR (HFD + AICAR) were injured by CTX
injection. Muscle was collected 1 h after the last AICAR treatment. A: Regeneration of TA muscle at 3 days postinjury (dpi) examined by H-E
staining showing necrotic muscle ﬁbers (#) and regenerating muscle ﬁbers (*). B: IHC staining of EMH+ muscle ﬁbers in TA muscle at 3 dpi
and quantiﬁcation. C: Regeneration of TA muscle at 7 dpi examined by H-E staining showing necrotic muscle ﬁbers (#) and regenerating
muscle ﬁbers (*). D: IHC staining of EMH+ muscle ﬁbers in TA muscle at 7 dpi and quantiﬁcation. E: Pax7, Myf5, MyoD, and myogenin
mRNA levels in TA muscle at 3 dpi. F and G: IHC staining of Pax7+ satellite cells in TA muscle at 3 dpi (F) and 7 dpi (G) and quantiﬁcation.
The dotted-line inset on each image shows magniﬁcation of the area marked by the solid-line box. H: FACS for Lin2/Sca-12/integrin a7+
satellite cells in TA muscle at 7 dpi. Data are mean 6 SEM (n = 3). Scale bars = 200 mm. *P < 0.05, **P < 0.01, ***P < 0.0001 vs. control.
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AICAR Treatment Recovered Muscle Regeneration
in Obese Mice Through AMPKa1 Activation

To further test whether elevated AMPK activity could
promote muscle regeneration in obese mice, we treated
obese mice with AICAR (250 mg/kg body weight/day i.p.),
an AMPK activator, from 1 day before muscle injury until
sampling days. AICAR treatment increased AMPK activity
in whole regenerating muscle and satellite cells (Supplementary Fig. 7A and B and Fig. 1D). More EMH+ muscle
ﬁbers were observed in mice treated with AICAR (Fig. 7A–
D). Consistently, the transcription levels of Pax7, Myf5,
MyoD, and myogenin were all enhanced in AICAR-treated
mice at 3 days postinjury (Fig. 7E), and satellite cell numbers were also increased (Fig. 7F–H). We further used
obese Pax7Cre/tdomato,EGFP mice to trace satellite and

derived cells; Pax7+ satellite cell–derived muscle ﬁbers
were increased in AICAR-treated obese Pax7Cre/tdomato,
EGFP mice (Supplementary Fig. 4A and B). The rescued
muscle regeneration in obese mice treated with AICAR
further demonstrated that the reduced muscle regeneration in obese mice was caused by attenuated AMPK activity, which could be effectively recovered by enhancing
AMPK activity. However, AICAR treatment failed to enhance myogenesis in control mice despite the increased
p-AMPKa level in muscle in response to AICAR treatment,
suggesting that elevated AMPK activity is only able to
enhance muscle regeneration when AMPK activity is compromised (Supplementary Fig. 7A, C–E).
Because AICAR treatment improves whole-body metabolism in obese mice, to further test whether AICAR
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Figure 8—AMPKa1 deﬁciency in satellite cells abolishes the promotion effect of AICAR on muscle regeneration of obese mice. Pax7Cre/
AMPKa1ﬂ/ﬂ were fed a high-fat diet (HFD). Satellite cell–speciﬁc AMPKa1 KO in Pax7Cre/AMPKa1ﬂ/ﬂ mice treated (HFD + AICAR) or not
treated (HFD) with AICAR was achieved by tamoxifen injection. TA muscle was injured by CTX injection following tamoxifen injection.
Muscle was collected 1 h after the last AICAR treatment. A: H-E staining of TA muscle at 3 and 7 days postinjury (dpi) showing necrotic
muscle ﬁbers (#) and regenerating muscle ﬁbers (*). B: IHC staining of EMH+ satellite cells in TA muscle at 3 and 7 dpi and quantiﬁcation. C:
IHC staining of Pax7+ satellite cells in TA muscle at 3 and 7 dpi and quantiﬁcation. The dotted-line inset on each image shows magniﬁcation
of the area marked by the solid-line box. D: FACS for Lin2/Sca-12/integrin a7+ satellite cells at 7 dpi. E: Pax7, Myf5, MyoD, and myogenin
mRNA levels in TA muscle at 3 dpi. F: Western blot analysis of p-AMPKa and AMPKa levels in muscle at 3 dpi. Data are mean 6 SEM (n =
3). Scale bars = 200 mm.
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DISCUSSION

Obesity has become an epidemic disease accompanied by
many severe complications, including insulin resistance
and cardiovascular disease (39,40). AMPK is an important
regulator of metabolism that is activated when calories are
restricted (15). Its activity is downregulated under the
obese condition, and elevated AMPK activity alleviates obesity and its associated metabolic dysfunctions through promoting glucose uptake in muscle and increasing the
sensitivity of animal to insulin (41–44). Muscle regeneration has been reported to be enhanced by calorie restriction, which may be due to enhanced AMPK activity,
although direct evidence is lacking (45). We demonstrate
that muscle regeneration in obese mice is impaired due to
decreased AMPKa1 activity in satellite cells and that
AMPKa1 KO reduces proliferation and myogenic capacity
of satellite cells during muscle regeneration. On the contrary, ﬁbrogenesis is enhanced in AMPKa1 KO mice. These
data demonstrate for the ﬁrst time in our knowledge the
role of AMPKa1 in regulating both proliferation and differentiation of satellite cells during muscle regeneration.
We further tested the effectiveness of AMPK as a target to facilitate muscle regeneration in obese mice. AMPK
activation induced by AICAR successfully improved muscle regeneration in the obese mice. Furthermore, KO of
AMPKa1 in satellite cells abolished the promoting effect
of AICAR treatment on muscle regeneration, strengthening
the notion that the enhanced muscle regeneration in
AICAR-treated obese mice is mainly due to elevated
AMPKa1 activity in satellite cells. However, the unchanged
muscle regeneration in mice fed the control diet in response to AICAR treatment suggests that AMPK activity
at a level higher than its normal physiological level does not
further enhance muscle regeneration. On the contrary,
chronic AMPK activation in muscle may induce muscle
atrophy, suggesting that more studies are required to optimize AMPK activity to promote muscle regeneration
without inducing side effects (46).
In summary, we show that AMPKa1 is a key factor
leading to impaired muscle regeneration in obese mice.
AMPK is important in muscle regeneration because it

199

increases the density of quiescent satellite cells, enhances
satellite cell proliferation, and promotes satellite cell myogenic differentiation in regenerating muscle. Therefore,
AMPK has multifaceted effects on muscle regeneration.
The data have the following important clinical applications:
1) AMPK activity is attenuated by a number of physiological factors, including obesity and diabetes, and 2) drugs
targeting AMPK are widely available as antidiabetic drugs,
which may be used to activate AMPK to facilitate muscle
regeneration in patients with obesity and diabetes.
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